Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/10885
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLim, Seok Ming-
dc.contributor.authorKatsifis, Andrew-
dc.contributor.authorVillemagne, Victor L-
dc.contributor.authorBest, Rene-
dc.contributor.authorJones, Gareth-
dc.contributor.authorSaling, Michael M-
dc.contributor.authorBradshaw, Jennifer-
dc.contributor.authorMerory, John-
dc.contributor.authorWoodward, Michael M-
dc.contributor.authorHopwood, Malcolm-
dc.contributor.authorRowe, Christopher C-
dc.date.accessioned2015-05-16T00:27:45Z
dc.date.available2015-05-16T00:27:45Z
dc.date.issued2009-09-16-
dc.identifier.citationJournal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 2009; 50(10): 1638-45en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/10885en
dc.description.abstractNeuroimaging is increasingly used to supplement the clinical diagnosis of dementia with Lewy bodies (DLB) by showing reduced occipital metabolism and perfusion and reduced striatal dopaminergic innervation. We aimed to optimize the interpretation of (18)F-FDG PET images for differentiating DLB from Alzheimer disease (AD) and to compare the results with dopamine transporter imaging using (123)I-beta-carbomethoxy-3ss-(4-iodophenyl)tropane ((123)I-beta-CIT) SPECT.Fourteen subjects with a clinical diagnosis of DLB and 10 with AD underwent both (18)F-FDG PET and (123)I-beta-CIT SPECT. Four DLB and 1 AD diagnoses were subsequently confirmed at autopsy. Diagnostic accuracy was calculated for visual interpretation by 3 readers of standard 3-plane and stereotactic surface projection (18)F-FDG PET images, receiver-operating-characteristic analysis of regional (18)F-FDG uptake, and a cutoff value for the striatal-to-occipital binding ratio of beta-CIT defined by receiver-operating-characteristic analysis.Visual interpretation of 3-plane (18)F-FDG PET images had a sensitivity of 83% and specificity of 93% for DLB, slightly higher than the results with the stereotactic surface projection images. Regionally, hypometabolism in the lateral occipital cortex had the highest sensitivity (88%), but relative preservation of the mid or posterior cingulate gyrus (cingulate island sign) had the highest specificity (100%). Region-of-interest analysis revealed that occipital hypometabolism and relative preservation of the posterior cingulate both had a sensitivity of 77% and specificity of 80%. beta-CIT achieved 100% accuracy and greater effect size than did (18)F-FDG PET (Cohen d = 4.1 vs. 1.9).Both (18)F-FDG PET and (123)I-beta-CIT SPECT appear useful for the diagnosis of DLB, although the latter provides more robust results. The cingulate island sign may enhance the specificity of (18)F-FDG PET.en
dc.language.isoenen
dc.subject.otherAgeden
dc.subject.otherAlzheimer Disease.metabolism.radionuclide imagingen
dc.subject.otherAutopsyen
dc.subject.otherCocaine.analogs & derivatives.diagnostic useen
dc.subject.otherCohort Studiesen
dc.subject.otherDiagnosis, Differentialen
dc.subject.otherDopamine Plasma Membrane Transport Proteins.metabolismen
dc.subject.otherFemaleen
dc.subject.otherFluorodeoxyglucose F18.diagnostic useen
dc.subject.otherGyrus Cinguli.radionuclide imagingen
dc.subject.otherHumansen
dc.subject.otherImage Interpretation, Computer-Assisteden
dc.subject.otherLewy Body Disease.metabolism.pathology.radionuclide imagingen
dc.subject.otherMaleen
dc.subject.otherPositron-Emission Tomographyen
dc.subject.otherROC Curveen
dc.subject.otherSensitivity and Specificityen
dc.subject.otherStaining and Labelingen
dc.subject.otherTomography, Emission-Computed, Single-Photonen
dc.titleThe 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies.en
dc.typeJournal Articleen
dc.identifier.journaltitleJournal of Nuclear Medicineen
dc.identifier.affiliationDepartment of Nuclear Medicine and Centre for PET, Austin Health, Victoria, Australiaen
dc.identifier.doi10.2967/jnumed.109.065870en
dc.description.pages1638-45en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/19759102en
dc.type.contentTexten
dc.type.austinJournal Articleen
local.name.researcherRowe, Christopher C
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptClinical Neuropsychology-
crisitem.author.deptThe Florey Institute of Neuroscience and Mental Health-
crisitem.author.deptAged Care-
crisitem.author.deptGeriatric Medicine-
crisitem.author.deptMolecular Imaging and Therapy-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

104
checked on Nov 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.